New Discovery Links Cancer Signaling Pathway to Blood-Brain and Blood-Retina Barrier Functions
Recent research uncovers a novel link between cancer signaling pathways, specifically MDM2-p53, and the regulation of blood-brain and blood-retina barriers, with implications for neurological and ocular health.
A recent study led by researchers from the University of Minnesota Medical School has revealed a surprising connection between cancer-related cellular pathways and the vascular functions of the retina and the brain. The team found that the MDM2-p53 signaling axis, well-known for its role in tumor suppression, also plays a significant role in maintaining the integrity of blood vessels in the central nervous system, including the retina.
Published in Science Signaling, the research demonstrates that p53, a critical protein in cancer prevention, can influence blood vessel health by downregulating NCAPH, a protein involved in vascular stability. This interaction appears to weaken the Norrin/Frizzled4 signaling pathway, which is essential for the development and maintenance of blood-tissue barriers such as the blood-brain barrier and the blood-retina barrier.
Blood-CNS barriers are crucial in regulating the exchange of nutrients and waste between the bloodstream and the nervous system, preventing issues like edema and neuroinflammation. The study highlights that increasing p53 levels, a strategy used in some cancer therapies, might inadvertently compromise these barriers, potentially leading to increased vascular permeability, neuroinflammation, and swelling.
Furthermore, the research identifies NCAPH as a potential candidate gene for familial exudative vitreoretinopathy (FEVR), a rare inherited eye condition affecting retinal blood vessels. These findings suggest caution in using MDM2 inhibitors—drugs that elevate p53—in cancer treatment, as they could disrupt vascular barrier functions.
The study emphasizes the need for further research into how modulation of p53 may impact vascular health, especially in the context of neurological and ocular diseases. It also opens avenues for exploring NCAPH as a target for vascular disorder therapeutics.
For more information, see the full study: Jacklyn Levey et al, The MDM2-p53 axis regulates norrin/frizzled4 signaling and blood-CNS barrier function, Science Signaling (2025). For details, visit: https://medicalxpress.com/news/2025-07-uncovers-link-cancer-pathway-blood.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Brain's Sleep Switch: A Molecular Signal Regulating Sleep and Wake Cycles
Discover how a single brain signal acts as a biological switch, controlling the initiation and ending of sleep through a molecular mechanism studied in C. elegans, providing insights into sleep regulation applicable to humans.
Promoting Healthy Aging: A Paradigm Shift in Research and Medical Practice
A new discussion paper calls for a shift in research and medicine to focus on understanding and targeting the aging process itself, aiming to promote healthier aging and reduce age-related diseases.
Discovery of Specialized Lung Cells Accelerates Repair After Smoke and Virus Exposure in Mice
Scientists have identified rare lung neuroendocrine cells that trigger rapid repair after exposure to smoke and viruses, with potential implications for respiratory health and metabolic disease prevention.
Innovative Compound Shows Promise in Enhancing Brain Recovery Post-Traumatic Injury
A groundbreaking study from the University of Georgia introduces CMX-2043, a promising drug that enhances the brain's natural healing process after traumatic injuries, addressing a major gap in current treatments.